Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7WZ63
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009895 | negative regulation of catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016553 | base conversion or substitution editing | 6 | 1 |
GO:0016554 | cytidine to uridine editing | 7 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031330 | negative regulation of cellular catabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043489 | RNA stabilization | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0048255 | mRNA stabilization | 5 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1902369 | negative regulation of RNA catabolic process | 7 | 1 |
GO:1902373 | negative regulation of mRNA catabolic process | 7 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903312 | negative regulation of mRNA metabolic process | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 229 | 233 | PF00656 | 0.404 |
CLV_C14_Caspase3-7 | 30 | 34 | PF00656 | 0.738 |
CLV_NRD_NRD_1 | 181 | 183 | PF00675 | 0.335 |
CLV_NRD_NRD_1 | 25 | 27 | PF00675 | 0.784 |
CLV_NRD_NRD_1 | 254 | 256 | PF00675 | 0.335 |
CLV_NRD_NRD_1 | 412 | 414 | PF00675 | 0.335 |
CLV_NRD_NRD_1 | 573 | 575 | PF00675 | 0.474 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 25 | 27 | PF00082 | 0.784 |
CLV_PCSK_KEX2_1 | 254 | 256 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 412 | 414 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 573 | 575 | PF00082 | 0.481 |
CLV_PCSK_PC7_1 | 408 | 414 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 102 | 106 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.386 |
CLV_PCSK_SKI1_1 | 604 | 608 | PF00082 | 0.588 |
DOC_CYCLIN_yCln2_LP_2 | 169 | 175 | PF00134 | 0.305 |
DOC_MAPK_gen_1 | 704 | 712 | PF00069 | 0.414 |
DOC_MAPK_RevD_3 | 167 | 182 | PF00069 | 0.402 |
DOC_PP1_RVXF_1 | 260 | 267 | PF00149 | 0.386 |
DOC_PP4_FxxP_1 | 336 | 339 | PF00568 | 0.335 |
DOC_PP4_FxxP_1 | 346 | 349 | PF00568 | 0.335 |
DOC_PP4_FxxP_1 | 568 | 571 | PF00568 | 0.474 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.432 |
DOC_USP7_MATH_1 | 201 | 205 | PF00917 | 0.266 |
DOC_USP7_MATH_1 | 230 | 234 | PF00917 | 0.480 |
DOC_USP7_MATH_1 | 321 | 325 | PF00917 | 0.322 |
DOC_USP7_MATH_1 | 439 | 443 | PF00917 | 0.342 |
DOC_USP7_MATH_1 | 545 | 549 | PF00917 | 0.434 |
DOC_USP7_MATH_1 | 563 | 567 | PF00917 | 0.559 |
DOC_USP7_MATH_1 | 572 | 576 | PF00917 | 0.470 |
DOC_USP7_MATH_1 | 85 | 89 | PF00917 | 0.430 |
DOC_WW_Pin1_4 | 157 | 162 | PF00397 | 0.425 |
DOC_WW_Pin1_4 | 335 | 340 | PF00397 | 0.334 |
DOC_WW_Pin1_4 | 418 | 423 | PF00397 | 0.335 |
LIG_14-3-3_CanoR_1 | 573 | 577 | PF00244 | 0.538 |
LIG_14-3-3_CanoR_1 | 738 | 743 | PF00244 | 0.463 |
LIG_Actin_WH2_2 | 690 | 708 | PF00022 | 0.462 |
LIG_AP2alpha_2 | 132 | 134 | PF02296 | 0.335 |
LIG_APCC_ABBA_1 | 270 | 275 | PF00400 | 0.466 |
LIG_APCC_ABBAyCdc20_2 | 262 | 268 | PF00400 | 0.266 |
LIG_APCC_ABBAyCdc20_2 | 574 | 580 | PF00400 | 0.544 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.645 |
LIG_BIR_III_4 | 440 | 444 | PF00653 | 0.335 |
LIG_BRCT_BRCA1_1 | 122 | 126 | PF00533 | 0.415 |
LIG_BRCT_BRCA1_1 | 65 | 69 | PF00533 | 0.820 |
LIG_Clathr_ClatBox_1 | 83 | 87 | PF01394 | 0.402 |
LIG_deltaCOP1_diTrp_1 | 238 | 245 | PF00928 | 0.402 |
LIG_deltaCOP1_diTrp_1 | 304 | 310 | PF00928 | 0.363 |
LIG_EH1_1 | 504 | 512 | PF00400 | 0.335 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.373 |
LIG_FHA_1 | 148 | 154 | PF00498 | 0.382 |
LIG_FHA_1 | 343 | 349 | PF00498 | 0.378 |
LIG_FHA_1 | 394 | 400 | PF00498 | 0.408 |
LIG_FHA_1 | 432 | 438 | PF00498 | 0.399 |
LIG_FHA_1 | 458 | 464 | PF00498 | 0.480 |
LIG_FHA_1 | 490 | 496 | PF00498 | 0.335 |
LIG_FHA_2 | 624 | 630 | PF00498 | 0.547 |
LIG_HP1_1 | 82 | 86 | PF01393 | 0.402 |
LIG_Integrin_isoDGR_2 | 602 | 604 | PF01839 | 0.532 |
LIG_LIR_Apic_2 | 345 | 349 | PF02991 | 0.331 |
LIG_LIR_Apic_2 | 565 | 571 | PF02991 | 0.482 |
LIG_LIR_Gen_1 | 123 | 134 | PF02991 | 0.363 |
LIG_LIR_Gen_1 | 237 | 247 | PF02991 | 0.459 |
LIG_LIR_Gen_1 | 304 | 315 | PF02991 | 0.363 |
LIG_LIR_Gen_1 | 396 | 405 | PF02991 | 0.381 |
LIG_LIR_Gen_1 | 96 | 104 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 123 | 129 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 237 | 243 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 304 | 310 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 396 | 400 | PF02991 | 0.381 |
LIG_LIR_Nem_3 | 580 | 585 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 692 | 697 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 716 | 721 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 96 | 101 | PF02991 | 0.413 |
LIG_PCNA_yPIPBox_3 | 486 | 495 | PF02747 | 0.432 |
LIG_Pex14_1 | 240 | 244 | PF04695 | 0.480 |
LIG_PTB_Apo_2 | 423 | 430 | PF02174 | 0.335 |
LIG_PTB_Phospho_1 | 423 | 429 | PF10480 | 0.480 |
LIG_Rb_pABgroove_1 | 642 | 650 | PF01858 | 0.372 |
LIG_SH2_CRK | 98 | 102 | PF00017 | 0.436 |
LIG_SH2_NCK_1 | 387 | 391 | PF00017 | 0.344 |
LIG_SH2_SRC | 31 | 34 | PF00017 | 0.756 |
LIG_SH2_STAP1 | 31 | 35 | PF00017 | 0.740 |
LIG_SH2_STAP1 | 578 | 582 | PF00017 | 0.559 |
LIG_SH2_STAT5 | 244 | 247 | PF00017 | 0.480 |
LIG_SH2_STAT5 | 519 | 522 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 718 | 721 | PF00017 | 0.382 |
LIG_SH3_3 | 130 | 136 | PF00018 | 0.319 |
LIG_SH3_3 | 139 | 145 | PF00018 | 0.319 |
LIG_SH3_3 | 169 | 175 | PF00018 | 0.460 |
LIG_SH3_3 | 244 | 250 | PF00018 | 0.335 |
LIG_SH3_3 | 396 | 402 | PF00018 | 0.355 |
LIG_SH3_3 | 76 | 82 | PF00018 | 0.627 |
LIG_SUMO_SIM_anti_2 | 508 | 514 | PF11976 | 0.335 |
LIG_SUMO_SIM_anti_2 | 524 | 530 | PF11976 | 0.335 |
LIG_SUMO_SIM_par_1 | 459 | 469 | PF11976 | 0.331 |
LIG_SUMO_SIM_par_1 | 82 | 88 | PF11976 | 0.402 |
LIG_TRFH_1 | 568 | 572 | PF08558 | 0.536 |
LIG_WRC_WIRS_1 | 86 | 91 | PF05994 | 0.447 |
LIG_WW_2 | 79 | 82 | PF00397 | 0.626 |
LIG_WW_3 | 570 | 574 | PF00397 | 0.565 |
MOD_CK1_1 | 156 | 162 | PF00069 | 0.391 |
MOD_CK1_1 | 329 | 335 | PF00069 | 0.361 |
MOD_CK1_1 | 338 | 344 | PF00069 | 0.347 |
MOD_CK1_1 | 442 | 448 | PF00069 | 0.351 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.787 |
MOD_CK1_1 | 689 | 695 | PF00069 | 0.443 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.490 |
MOD_CK2_1 | 623 | 629 | PF00069 | 0.393 |
MOD_Cter_Amidation | 252 | 255 | PF01082 | 0.335 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.483 |
MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.368 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.353 |
MOD_GlcNHglycan | 219 | 222 | PF01048 | 0.355 |
MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.403 |
MOD_GlcNHglycan | 350 | 353 | PF01048 | 0.335 |
MOD_GlcNHglycan | 355 | 358 | PF01048 | 0.335 |
MOD_GlcNHglycan | 440 | 444 | PF01048 | 0.331 |
MOD_GlcNHglycan | 465 | 471 | PF01048 | 0.461 |
MOD_GlcNHglycan | 515 | 518 | PF01048 | 0.342 |
MOD_GlcNHglycan | 558 | 561 | PF01048 | 0.620 |
MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.793 |
MOD_GlcNHglycan | 565 | 568 | PF01048 | 0.467 |
MOD_GlcNHglycan | 608 | 611 | PF01048 | 0.390 |
MOD_GlcNHglycan | 649 | 652 | PF01048 | 0.524 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.755 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.338 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.402 |
MOD_GSK3_1 | 230 | 237 | PF00069 | 0.480 |
MOD_GSK3_1 | 334 | 341 | PF00069 | 0.350 |
MOD_GSK3_1 | 418 | 425 | PF00069 | 0.422 |
MOD_GSK3_1 | 431 | 438 | PF00069 | 0.252 |
MOD_GSK3_1 | 439 | 446 | PF00069 | 0.331 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.734 |
MOD_GSK3_1 | 738 | 745 | PF00069 | 0.490 |
MOD_N-GLC_1 | 109 | 114 | PF02516 | 0.308 |
MOD_N-GLC_1 | 201 | 206 | PF02516 | 0.439 |
MOD_N-GLC_1 | 230 | 235 | PF02516 | 0.399 |
MOD_N-GLC_1 | 431 | 436 | PF02516 | 0.480 |
MOD_N-GLC_1 | 623 | 628 | PF02516 | 0.544 |
MOD_N-GLC_1 | 689 | 694 | PF02516 | 0.513 |
MOD_N-GLC_1 | 96 | 101 | PF02516 | 0.420 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.434 |
MOD_NEK2_1 | 342 | 347 | PF00069 | 0.335 |
MOD_NEK2_1 | 457 | 462 | PF00069 | 0.447 |
MOD_NEK2_1 | 556 | 561 | PF00069 | 0.611 |
MOD_NEK2_1 | 647 | 652 | PF00069 | 0.498 |
MOD_NEK2_1 | 721 | 726 | PF00069 | 0.288 |
MOD_NEK2_1 | 742 | 747 | PF00069 | 0.524 |
MOD_NEK2_2 | 120 | 125 | PF00069 | 0.480 |
MOD_PIKK_1 | 135 | 141 | PF00454 | 0.335 |
MOD_PIKK_1 | 210 | 216 | PF00454 | 0.335 |
MOD_PIKK_1 | 255 | 261 | PF00454 | 0.383 |
MOD_PIKK_1 | 443 | 449 | PF00454 | 0.335 |
MOD_PIKK_1 | 484 | 490 | PF00454 | 0.484 |
MOD_PIKK_1 | 586 | 592 | PF00454 | 0.686 |
MOD_PIKK_1 | 70 | 76 | PF00454 | 0.551 |
MOD_PIKK_1 | 96 | 102 | PF00454 | 0.480 |
MOD_PK_1 | 674 | 680 | PF00069 | 0.576 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.791 |
MOD_PKA_2 | 572 | 578 | PF00069 | 0.540 |
MOD_PKA_2 | 586 | 592 | PF00069 | 0.581 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.743 |
MOD_PKB_1 | 51 | 59 | PF00069 | 0.750 |
MOD_Plk_1 | 431 | 437 | PF00069 | 0.447 |
MOD_Plk_1 | 623 | 629 | PF00069 | 0.412 |
MOD_Plk_1 | 96 | 102 | PF00069 | 0.420 |
MOD_Plk_4 | 149 | 155 | PF00069 | 0.266 |
MOD_Plk_4 | 329 | 335 | PF00069 | 0.419 |
MOD_Plk_4 | 362 | 368 | PF00069 | 0.346 |
MOD_Plk_4 | 374 | 380 | PF00069 | 0.312 |
MOD_Plk_4 | 458 | 464 | PF00069 | 0.402 |
MOD_Plk_4 | 505 | 511 | PF00069 | 0.336 |
MOD_Plk_4 | 623 | 629 | PF00069 | 0.401 |
MOD_Plk_4 | 668 | 674 | PF00069 | 0.557 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.419 |
MOD_ProDKin_1 | 157 | 163 | PF00069 | 0.425 |
MOD_ProDKin_1 | 335 | 341 | PF00069 | 0.334 |
MOD_ProDKin_1 | 418 | 424 | PF00069 | 0.335 |
TRG_ENDOCYTIC_2 | 244 | 247 | PF00928 | 0.447 |
TRG_ENDOCYTIC_2 | 387 | 390 | PF00928 | 0.344 |
TRG_ENDOCYTIC_2 | 519 | 522 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 718 | 721 | PF00928 | 0.411 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.385 |
TRG_ER_diArg_1 | 181 | 183 | PF00400 | 0.336 |
TRG_ER_diArg_1 | 24 | 26 | PF00400 | 0.773 |
TRG_ER_diArg_1 | 254 | 256 | PF00400 | 0.335 |
TRG_ER_diArg_1 | 572 | 574 | PF00400 | 0.495 |
TRG_NES_CRM1_1 | 636 | 649 | PF08389 | 0.473 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HT36 | Leptomonas seymouri | 63% | 100% |
A0A1X0NYA6 | Trypanosomatidae | 52% | 100% |
A0A3R7MPK5 | Trypanosoma rangeli | 51% | 100% |
A4HEJ8 | Leishmania braziliensis | 84% | 100% |
A4I1K0 | Leishmania infantum | 99% | 100% |
C9ZK34 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9AXN4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4Q9T7 | Leishmania major | 94% | 100% |
V5BHU4 | Trypanosoma cruzi | 51% | 100% |